About Asset Management Ventures
Asset Management Ventures is a venture capital firm founded in 1965. It is primarily based out of Palo Alto, United States. As of May 2025, Asset Management Ventures has invested in 78 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series B round of Outcomes4Me Overall, Asset Management Ventures portfolio has seen 2 unicorns, 4 IPOs and 27 acquisitions including key companies like Amgen, Biogen and Twist Bioscience. A lot of funds co-invest with Asset Management Ventures, with names like iSeed Ventures sharing a substantial percentage of its portfolio. Asset Management Ventures has team of 4 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Seed & 6 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Asset Management Ventures' List of Top Investments
Asset Management Ventures has a portfolio of 78 companies, including 2 unicorns. Their most notable investments are in Autonomize and Mozio.Their portfolio spans across United States, Canada, Germany and 2 more locations. They have invested in Life Sciences, Enterprise Applications, High Tech and 22 other sectors, across stages such as Series A, Seed and 6 more. Here is the list of top investments by Asset Management Ventures:1. Amgen
Developer of pharmaceutical products for treating multiple diseases. It manufactures and market human therapeutics based on advances in cellular and molecular biology. It markets human therapeutic products in the areas of hematology, oncology, and inflammation. In 2022, the company recorded annual revenues of $26.32B and a net profit of $6.55B.
Key facts about Amgen
- Founded Year: 1980
- Location: Thousand Oaks (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Employee Count: 41,670 as on Sep 30, 2026
- Investors: Digital Pharma Lab, Amgen Business Development and 11 Others
- Latest Funding Round: Post IPO, Mar 12, 2012, $*****
- Highlight: Public
2. Biogen
Developer of therapies for neurodegenerative and immunology disorders. The company has developed a pipeline of drugs for Alzheimer's disease Amyotrophic lateral sclerosis (ALS), Angelman syndrome, Brain contusion, Multiple sclerosis (MS), Multiple system atrophy (MSA), Ophthalmology, Pain, and more.
Key facts about Biogen
- Founded Year: 1978
- Location: Cambridge (United States)
- Annual Revenue: $1B+ as on Dec 31, 2025
- Stage: Public
- Total Funding till date: $80M
- Employee Count: 7,853 as on Sep 30, 2026
- Investors: Berkshire Hathaway, Digital Pharma Lab and 11 Others
- Latest Funding Round: Post IPO, Feb 13, 2024, $*****
- Highlight: Public
3. HealthTap
HealthTap provides a mobile and web platform for patients to connect with its digital community of doctors to get answers for any of their health questions. Other services include its Concierge program, which helps patients connect with their personal doctors; RateRx program, where doctors rate and review certain medications.
Key facts about HealthTap
- Founded Year: 2010
- Location: Palo Alto (United States)
- Stage: Series B
- Total Funding till date: $37.9M
- Employee Count: 160 as on Sep 30, 2026
- Investors: Tugboat Ventures, Vformation and 15 Others
- Latest Funding Round: Series B, May 08, 2013, $*****
- Highlight: Editors' Pick
Developer of a semiconductor-based DNA synthesis platform. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA which is used in diverse fields of medicine, agriculture, industrial chemicals and data storage. It offers synthetic genes, oligo pools, and NGS target enrichment to support research and innovation
Key facts about Twist Bioscience
- Founded Year: 2013
- Location: San Francisco (United States)
- Annual Revenue: $100M - $500M as on Sep 30, 2025
- Stage: Public
- Total Funding till date: $321M
- Employee Count: 1,311 as on Sep 30, 2026
- Investors: Foresite Capital, Fidelity Investments and 39 Others
- Latest Funding Round: Series F, Apr 02, 2018, $*****
- Highlight: Public
5. Welldoc
WellDoc’s flagship product, BlueStar, is a Mobile Prescription Therapy that enables patients to self-manage their diabetes through real-time motivational, behavioral, and educational coaching. Personalized coaching is provided using patented algorithms and real-time analysis of patient diabetes data. BlueStar requires a prescription from a licensed healthcare provider and can be dispensed and reimbursed through a pharmacy.
Key facts about Welldoc
- Founded Year: 2005
- Location: Columbia (United States)
- Stage: Series B
- Total Funding till date: $82.1M
- Employee Count: 432 as on Sep 30, 2026
- Investors: Samsung Venture Investment, Hudson River Capital Partners and 13 Others
- Latest Funding Round: Series B, Mar 01, 2016, $*****
- Highlight: Editors' Pick
Asset Management Ventures' Year-on-Year Investment Trends
Asset Management Ventures has invested in 78 companies over the last 22 years, with an average of 1 new investment annually in the last 10 years. In 2025, it made 2 investments. Its most recent first time investment was in Best Heart Test and most recent follow-on round was in Outcomes4Me.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 2 | 2 |
2024 | 1 | 0 | 1 |
2023 | 2 | 0 | 2 |
2022 | 1 | 1 | 2 |
2021 | 2 | 0 | 2 |
2020 | 1 | 2 | 3 |
2019 | 2 | 1 | 3 |
2018 | 2 | 0 | 2 |
2017 | 2 | 2 | 4 |
Asset Management Ventures' Investments by Stage
Asset Management Ventures has made 19 investments in Series A stage with an average round size of $10.8M, 10 investments in Seed stage with an average round size of $2.02M and 9 investments in Series B stage with an average round size of $20.4M.Stage of entry | No. of Investments |
|---|---|
Series A | 19 |
Seed | 10 |
Series B | 9 |
Series D | 4 |
Series C | 2 |
Others | 3 |
Note: We have considered here, only first round of investments
Asset Management Ventures' Investments by Sector
Asset Management Ventures has a diverse portfolio, with companies operating in the Life Sciences, HealthTech, Enterprise Applications, High Tech and Consumer. Notably, it has invested in 71 Tech companies, 62 Enterprise (B2B) companies, 36 Software companies and at least 18 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 24 |
HealthTech | 18 |
Enterprise Applications | 16 |
High Tech | 10 |
Consumer | 6 |
Others | 33 |
Note: We have considered here, only first round of investments
Asset Management Ventures' Investments by Geography
Asset Management Ventures has made most investments in United States (45), followed by Canada where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 45 |
Canada | 1 |
Germany | 1 |
United Kingdom | 1 |
Note: We have considered here, only first round of investments
Asset Management Ventures' recent investments
Asset Management Ventures has not made any investment in 2026 so far.Here are the most recent investments by Asset Management Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
May 29, 2025 | United States | Series B | 1668 | [+6] | |
May 28, 2025 | United States | Series A | 1911 | [+4] | |
Jun 11, 2024 | United States | Series A | 2456 | [+1] | |
Jul 24, 2023 | United States | Seed | 8956 | [+4] | |
Apr 10, 2023 | United States | Seed | 8284 | [+2] |
Unicorns in Asset Management Ventures' Portfolio
Asset Management Ventures has 2 unicorns in its portfolio - Freenome Health and Reify Health. The most recent unicorn in their portfolio is Freenome Health. It became a unicorn in 2022, 4 years after Asset Management Ventures first invested in it.Here is a list of unicorns in Asset Management Ventures' portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
67 | Provider of a deep learning platform for detecting circulating cancer-related markers | 2014 | - | Series E | adekwsb | ||
50 | Mobile health platform for doctors to manage clinical trials | 2012 | Boston | Series D | agtkzuq |
IPOs and Publicly Listed companies in Asset Management Ventures' Portfolio
4 of Asset Management Ventures' portfolio companies have become public. Twist Bioscience got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2018 at marketcap of $70M and Capnia got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $42.1M.Here are Asset Management Ventures' portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 31, 2018 | - | - | 4305 | |
Nov 13, 2014 | May 03, 2004 | Series B | 6475 | |
Sep 16, 1991 | - | - | 8397 | |
Oct 01, 1984 | - | - | 5361 |
Acquired companies in Asset Management Ventures' Portfolio
27 companies from Asset Management Ventures' portfolio have been acquired. The most recent acquisition was Loomia in Aug 2026 by Unichem Pharmaceuticals for $*****.Here are Asset Management Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 06, 2026 | Apr 02, 2008 | Series A | 6807 | |
May 01, 2026 | Apr 24, 2013 | Series B | 3530 | |
Mar 05, 2025 | Nov 04, 2004 | Series C | 4481 | |
Apr 30, 2024 | Oct 20, 2022 | Series B | 6431 | |
Jul 11, 2022 | Jul 16, 2007 | Series C | 9668 |
Team profile of Asset Management Ventures
Asset Management Ventures has a team of 4 members including 3 Partners located in United States. Asset Management Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Asset Management Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Boston | - | - | |
Partner | Palo Alto | - | - | |
Partner | Palo Alto | - | - |
Co-investors of Asset Management Ventures
Over the past 22 years, 420 investors have co-invested in Asset Management Ventures's portfolio companies. This includes funds and angels.
- Invested before Asset Management Ventures: Rock Health, Plug and Play Tech Center and 92 others have invested in rounds before Asset Management Ventures. There are 2 companies where Rock Health has invested before Asset Management Ventures and 2 companies where Plug and Play Tech Center has invested before Asset Management Ventures.
- Top Co-investors of Asset Management Ventures: 139 investors entered a company along with Asset Management Ventures. These include investors like iSeed Ventures (3 companies).
- Invested after Asset Management Ventures: A total of 187 investors have invested in Asset Management Ventures's portfolio after their investments. Top Investors include HHS (5 companies), Revelation Partners (2 companies) and Pappas Capital (2 companies).
Recent News related to Asset Management Ventures
•
Outcomes4Me Secures $21M in Funding to Accelerate AI Innovation and Drive Global Expansion in Cancer CarePR Newswire•May 30, 2025•Outcomes4Me, LabCorp, Salica Investments, Forecast Labs and 4 others
•
Generali Near Deal With Natixis for Asset Management VentureInsurance Journal•Jan 16, 2025•Natixis, Asset Management Ventures
•
Endless Health Raises $4.5M in Seed FundingFinSMEs•Jul 23, 2024•Best Heart Test, Next Coast Ventures, Asset Management Ventures, Endless Health
•
Basys.ai Raises $2.4M in Pre-Seed FundingFinSMEs•Aug 11, 2023•Basys.ai, Nina Capital, Lilly, Mayo Clinic and 3 others
•
Carta Healthcare Closes $25M Series B FundingFinSMEs•Jun 08, 2023•Carta Healthcare, Memorial Hermann, UnityPoint Health, Frist Cressey Ventures and 7 others
•
Carta Healthcare Raises $25M for AI-Powered Clinical Data AbstractionHIT Consultant•Jun 08, 2023•Carta Healthcare, Memorial Hermann, UnityPoint Health, Paramark Ventures and 7 others
•
Autonomize has filed a notice of an exempt offering of securities to raise $4,024,994.00 in New Equity Investment.intelligence360•May 01, 2023•Autonomize, ATX Venture Partners, Loop Ventures, Next Practices Group and 2 others
•
US Tech Startup SubjectWell Secures $35 Million in Investment, Focuses Growth in South African OperationsBusiness Wire•Nov 10, 2022•SubjectWell, Asset Management Ventures
•
SAIL Announces $4.7 Million Seed Fundraising Round to Help Advance Life-Saving Clinical ResearchACCESSWIRE•Nov 08, 2022•Array Insights, Asset Management Ventures, Mozilla, FutureLabs Ventures and 1 other
•
Carta Healthcare Secures $20 Million Series B Funding to Help Additional Health Systems Improve Patient Care Amid Challenging Global Economy, Pandemic Turbulence, and Downturn in VC FundingBusiness Wire•Nov 02, 2022•Carta Healthcare, Paramark Ventures, Frist Cressey Ventures, American College of Cardiology and 6 others
